Palvella Therapeutics (PVLA) earnings, Nov 5, 2026: EPS −65%, stock −3.3%
In brief
Palvella Therapeutics reported on Nov 5, 2026. Earnings per share changed −65% year over year, 4.7% above the estimate; revenue 0%. The stock opened with a +2.7% gap and closed the day −3.3% (Nov 5, 2026). The stock is now 5.9% below its 52-week high, +107.1% over 12 months.
EPS vs estimate+4.7%
EPS, YoY−65%
Revenue, YoY0%
Gap · day+2.7% · −3.3%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 4, 2026 | −3.9% | +8.0% |
| Nov 5, 2026 | +2.7% | −3.3% |
Next-quarter estimates, ratings and the PVLA chart are in the terminal.
Open the terminalFAQ
When is Palvella Therapeutics's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did Palvella Therapeutics stock react to the report?
Opening gap +2.7%, day's result −3.3%.
Did Palvella Therapeutics's earnings grow?
Earnings per share fell 65% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.